197 related articles for article (PubMed ID: 28765954)
21. Overexpression of caspase recruitment domain (CARD) membrane-associated guanylate kinase 1 (CARMA1) and CARD9 in primary gastric B-cell lymphoma.
Nakamura S; Nakamura S; Matsumoto T; Yada S; Hirahashi M; Suekane H; Yao T; Goda K; Iida M
Cancer; 2005 Nov; 104(9):1885-93. PubMed ID: 16177990
[TBL] [Abstract][Full Text] [Related]
22. Study of individual domains contributing to MALT1 dimerization in BCL10-independent and dependent assembly.
Kuo BJ; Lin SC; Tu YF; Huang PH; Lo YC
Biochem Biophys Res Commun; 2024 Jul; 717():150029. PubMed ID: 38714015
[TBL] [Abstract][Full Text] [Related]
23. The CBM complex: A growing multiplicity of cellular functions, regulatory mechanisms and connections to human disease.
Schaefer BC
Cell Immunol; 2020 Oct; 356():104189. PubMed ID: 32771677
[No Abstract] [Full Text] [Related]
24. Germline CBM-opathies: From immunodeficiency to atopy.
Lu HY; Biggs CM; Blanchard-Rohner G; Fung SY; Sharma M; Turvey SE
J Allergy Clin Immunol; 2019 May; 143(5):1661-1673. PubMed ID: 31060714
[TBL] [Abstract][Full Text] [Related]
25. CARD9 versus CARMA1 in innate and adaptive immunity.
Hara H; Saito T
Trends Immunol; 2009 May; 30(5):234-42. PubMed ID: 19359218
[TBL] [Abstract][Full Text] [Related]
26. Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons.
Wang W; Chang X; Yao W; Wei N; Huo N; Wang Y; Wei Q; Liu H; Wang X; Zhang S; Yang Z; Xiao S
J Virol; 2019 Dec; 93(24):. PubMed ID: 31554683
[TBL] [Abstract][Full Text] [Related]
27. Structural insights into the assembly of CARMA1 and BCL10.
Li S; Yang X; Shao J; Shen Y
PLoS One; 2012; 7(8):e42775. PubMed ID: 22880103
[TBL] [Abstract][Full Text] [Related]
28. Bcl10 phosphorylation-dependent droplet-like condensation positively regulates DNA virus-induced innate immune signaling.
Yang D; Pei G; Dong S; Zhang W; Deng H; Zhao X; Li P; Lin X
Sci China Life Sci; 2023 Feb; 66(2):283-297. PubMed ID: 36115893
[TBL] [Abstract][Full Text] [Related]
29. Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-Canadians.
Gavino C; Hamel N; Zeng JB; Legault C; Guiot MC; Chankowsky J; Lejtenyi D; Lemire M; Alarie I; Dufresne S; Boursiquot JN; McIntosh F; Langelier M; Behr MA; Sheppard DC; Foulkes WD; Vinh DC
J Allergy Clin Immunol; 2016 Apr; 137(4):1178-1188.e7. PubMed ID: 26521038
[TBL] [Abstract][Full Text] [Related]
30. The autophagy regulator Rubicon is a feedback inhibitor of CARD9-mediated host innate immunity.
Yang CS; Rodgers M; Min CK; Lee JS; Kingeter L; Lee JY; Jong A; Kramnik I; Lin X; Jung JU
Cell Host Microbe; 2012 Mar; 11(3):277-89. PubMed ID: 22423967
[TBL] [Abstract][Full Text] [Related]
31. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
Wegener E; Krappmann D
Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
[TBL] [Abstract][Full Text] [Related]
32. Chimeric and mutant CARD9 constructs enable analyses of conserved and diverged autoinhibition mechanisms in the CARD-CC protein family.
Staal J; Driege Y; Van Gaever F; Steels J; Beyaert R
FEBS J; 2024 Mar; 291(6):1220-1245. PubMed ID: 38098267
[TBL] [Abstract][Full Text] [Related]
33. Novel disulfide bond-mediated dimerization of the CARD domain was revealed by the crystal structure of CARMA1 CARD.
Jang TH; Park JH; Park HH
PLoS One; 2013; 8(11):e79778. PubMed ID: 24224005
[TBL] [Abstract][Full Text] [Related]
34. The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.
Ekambaram P; Lee JL; Hubel NE; Hu D; Yerneni S; Campbell PG; Pollock N; Klei LR; Concel VJ; Delekta PC; Chinnaiyan AM; Tomlins SA; Rhodes DR; Priedigkeit N; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
Cancer Res; 2018 Mar; 78(5):1225-1240. PubMed ID: 29259013
[TBL] [Abstract][Full Text] [Related]
35. Caspase recruitment domain-containing protein 9 signaling in innate immunity and inflammation.
Roth S; Ruland J
Trends Immunol; 2013 Jun; 34(6):243-50. PubMed ID: 23523010
[TBL] [Abstract][Full Text] [Related]
36. BCL10 - Bridging CARDs to Immune Activation.
Gehring T; Seeholzer T; Krappmann D
Front Immunol; 2018; 9():1539. PubMed ID: 30022982
[TBL] [Abstract][Full Text] [Related]
37. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity.
Gross O; Gewies A; Finger K; Schäfer M; Sparwasser T; Peschel C; Förster I; Ruland J
Nature; 2006 Aug; 442(7103):651-6. PubMed ID: 16862125
[TBL] [Abstract][Full Text] [Related]
38. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation.
Marasco D; Stilo R; Sandomenico A; Monti SM; Tizzano B; de Capua A; Varricchio E; Liguoro D; Zotti T; Formisano S; Ruvo M; Vito P
Biochem J; 2009 Aug; 422(3):553-61. PubMed ID: 19538180
[TBL] [Abstract][Full Text] [Related]
39. Editorial: CARMA Proteins: Playing a Hand of Four CARDs.
Bornancin F; Snow AL
Front Immunol; 2019; 10():1217. PubMed ID: 31231375
[No Abstract] [Full Text] [Related]
40. Cutting edge: the "death" adaptor CRADD/RAIDD targets BCL10 and suppresses agonist-induced cytokine expression in T lymphocytes.
Lin Q; Liu Y; Moore DJ; Elizer SK; Veach RA; Hawiger J; Ruley HE
J Immunol; 2012 Mar; 188(6):2493-7. PubMed ID: 22323537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
